We recently published a list of 12 Most Profitable Pharmaceutical Stocks Right Now. In this article, we are going to take a ...

Agios Pharmaceuticals Inc (AGIO) reports a 22% revenue increase and significant milestone payments ... (Nasdaq: AGIO), a leader in cellular metabolism and pyruvate kinase (PK) activation pioneering ...

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced financial results for its 2024 fiscal year ended September 30, 2024. The Company is hosting a conference ...

Dividend stocks provide investors with reliable passive income. These four health care picks look like outstanding ideas now.

We recently compiled a list of the 10 Most Promising Cancer Stocks According to Hedge Funds. In this article, we are going to ...

The company reported $1.04 EPS for the quarter, beating analysts’ consensus estimates of $1.01 by $ ... and Daliresp for ...

Citigroup initiated coverage on shares of Akero Therapeutics (NASDAQ:AKRO – Free Report) in a research note issued to investors on Monday, Marketbeat Ratings reports. The firm issued a buy rating and ...

TD Cowen analyst Ritu Baral maintained a Buy rating on Sagimet Biosciences, Inc. Class A (SGMT – Research Report) today. The company’s shares ...

Delivering on commitments, executing ahead of expectations, and raising guidanceInnovation driving sustained growth across many franchises: TAVR, PFA, Leadless Pacemakers, Diabetes, Spine ...

Frontiers Science Center for Synthetic Biology (Ministry of Education), Key Laboratory of Systems Bioengineering, and School of Chemical Engineering and Technology, Tianjin University, Tianjin 300350, ...

Analyst Ed Arce from H.C. Wainwright maintained a Buy rating on Sagimet Biosciences, Inc. Class A (SGMT – Research Report) and keeping ...